The Market Reports

Synopsis

The global market for Blockchain In Pharmaceutical was estimated to be worth US$ 4667 million in 2024 and is forecast to a readjusted size of US$ 96750 million by 2031 with a CAGR of 55.0% during the forecast period 2025-2031.

Blockchain In Pharmaceutical refers to the application of blockchain technology in the healthcare field. It allows personal health information to be stored in the network, enabling healthcare providers to have broader access to patients' basic health information while securely storing this information through encrypted signatures.

Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91%. For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69%.

Market Drivers

1. Supply Chain Transparency and Traceability
Blockchain provides an immutable and decentralized ledger that enables end-to-end visibility across the pharmaceutical supply chain. This helps combat counterfeit drugs, track the movement of raw materials and finished products, and ensure authenticity, which is critical for patient safety.

2. Counterfeit Drug Prevention
Counterfeit drugs pose a significant threat to global health, costing the industry billions annually. Blockchain’s ability to create tamper-proof records ensures that every drug can be traced back to its origin, reducing the risk of counterfeit products entering the market.

3. Regulatory Compliance
Pharmaceutical companies face stringent regulations from agencies like the FDA and EMA. Blockchain simplifies compliance by providing a transparent and auditable record of every transaction, from manufacturing to distribution, ensuring adherence to regulatory requirements.

4. Improved Drug Recall Management
In the event of a drug recall, blockchain enables rapid identification of affected batches and their distribution channels. This minimizes the impact on patients and reduces financial losses for manufacturers.

5. Enhanced Data Security and Privacy
Blockchain’s cryptographic algorithms ensure secure storage and sharing of sensitive data, such as patient records and clinical trial data. This is particularly important in an era of increasing cyber threats and data breaches.

This report aims to provide a comprehensive presentation of the global market for Blockchain In Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blockchain In Pharmaceutical by region & country, by Type, and by Application.

The Blockchain In Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blockchain In Pharmaceutical.

Market Segmentation

By Company

• IBM
• AWS
• Microsoft
• SAP
• Chronicled
• Embleema
• FarmaTrust
• Guardtime Federal

Segment by Type

• Private Blockchain
• Hybrid Blockchain

Segment by Application

• Supply Chain Logistics
• Drug Safety
• Clinical Trial Management
• IOMT & Cyber Security

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.